Fund Details
Overview
Investment portfolio
15rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Blue Dot Touch | Jul 2025Participated | $14 MSeries B | |
CanSemi | Jul 2022Participated | $672 MOther Equity | |
Data Grand | Mar 2022Participated | $91 MSeries C | |
Yunzhangfang | Feb 2022Participated | $100 MSeries E | |
CalciMedica | Mar 2021Led | $21 MSeries D | |
Pi Therapeutics | May 2019Participated | $20 MSeries B | |
RadRock Tech | May 2019Led | $100 MSeries A | |
Sitka Biopharma | Oct 2018Led | $2 MOther Equity | |
Canary Medical | May 2018Led | $10 MOther Equity | |
ARTMS | Dec 2017Led | $3 MOther Equity | |
Bioarray Therapeutics | Oct 2017Participated | $4 MSeries B | |
Fotor | Sep 2017Led | $8 MSeries B | |
Blue Dot Touch | Jul 2025Participated | $14 MSeries B | |
CanSemi | Jul 2022Participated | $672 MOther Equity | |
Data Grand | Mar 2022Participated | $91 MSeries C | |
Yunzhangfang | Feb 2022Participated | $100 MSeries E | |
CalciMedica | Mar 2021Led | $21 MSeries D | |
Pi Therapeutics | May 2019Participated | $20 MSeries B | |
RadRock Tech | May 2019Led | $100 MSeries A | |
Sitka Biopharma | Oct 2018Led | $2 MOther Equity | |
Canary Medical | May 2018Led | $10 MOther Equity | |
ARTMS | Dec 2017Led | $3 MOther Equity | |
Bioarray Therapeutics | Oct 2017Participated | $4 MSeries B | |
Fotor | Sep 2017Led | $8 MSeries B |
15 Items
15
Items
...
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 1 | 1 |
| Series B | 1 | 4 |
| Series C+ | 1 | 2 |
| Other Equity | 4 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Apr '17 | 1 |
| May '17 | 0 |
| Jun '17 | 1 |
| Jul '17 | 1 |
| Aug '17 | 0 |
| Sep '17 | 1 |
| Oct '17 | 1 |
| Nov '17 | 0 |
| Dec '17 | 1 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 1 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 1 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 2 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 1 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 1 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 1 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 9 |
| Enterprise Software | 4 |
| Hardware & Robotics | 3 |
| Manufacturing | 3 |
| Space & Frontier Tech | 3 |
| Data, Analytics & IT | 2 |
| Consumer & Lifestyle | 1 |
| Networks, Cloud & Communication | 1 |
| Marketing & Advertising | 1 |
| Fintech | 1 |
| Media & Entertainment | 1 |
| Cybersecurity & Privacy | 1 |
| AI & Machine Learning | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 3 |
| $5M-$10M | 2 |
| $10M-$25M | 6 |
| $25M-$50M | 0 |
| $50M-$100M | 1 |
| $100M-$250M | 2 |
| $250M-$500M | 0 |
| $500M-$1B | 1 |
| $1B+ | 0 |
Deals By Geography
Top 4 of 4 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| China | 6 |
| United States | 4 |
| Canada | 4 |
| Israel | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Quark Venture | 9 |
| Shenzhen Capital Group | 2 |
| 4490 Ventures | 1 |
| Apax Partners | 1 |
| Arkin Bio Ventures | 1 |
| BDC Capital | 1 |
| BioScience Managers | 1 |
| CBG | 1 |
| CITIC Securities | 1 |
| CMB International | 1 |
| Connecticut Innovations | 1 |
| CSC Venture Capital | 1 |
| CTI Life Sciences Fund | 1 |
| Fosun Capital | 1 |
| GF Investment | 1 |
| GHS Fund | 1 |
| Healthlink Capital | 1 |
| Huacang Capital | 1 |
| Hundreds Capital | 1 |
| InvesTarget | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 7 | 47% |
| Participating | 8 | 53% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 29% |
| Co-led | 5 | 71% |
Team
Hongwei Liu
CEO
Tim Tu
Director, Global Markets
